Cancer continues to be a formidable challenge globally, with traditional drug discovery methods focusing on cytotoxic agents and targeted therapies altering the landscape of cancer prognosis and ...
纽约 - 以非侵入性药物检测技术闻名的医疗技术公司Intelligent Bio Solutions Inc. (NASDAQ: INBS)公布了截至2024年9月30日的2025财年第一季度初步未经审计的收入结果。该公司宣布,三个月内收入同比增长10%,环比增长20%,约为0.87百万美元。 该公司的Intelligent Fingerprinting Drug Screening System ...
MIRA Pharmaceuticals stock rises as new preclinical data reveal its oral ketamine analog Ketamir-2 is 60% more effective than gabapentin in pain relief.